{"id":"W2006721545","doi":"10.1007/s10637-005-1439-x","title":"A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer","year":2005,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Pharmacokinetics; Paclitaxel; Medicine; Neutropenia; Pharmacology; Toxicity; P-glycoprotein; Chemotherapy; Febrile neutropenia; Internal medicine; Multiple drug resistance; Antibiotics; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001039009,0.001136522,0.002291573,0.0005315449,0.0005821826,0.001105001,0.0007688111,0.0009829988,0.002173109],"category_scores_gemma":[0.001479844,0.000788252,0.001455843,0.0007809842,0.001158558,0.001159097,0.0002637704,0.004438587,0.0005159447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001131965,"about_ca_system_score_gemma":0.001907303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001818871,"about_ca_topic_score_gemma":0.003820023,"domain_scores_codex":[0.9994938,0.0002533463,0.00001963867,0.0000801963,0.00004749263,0.0001054329],"domain_scores_gemma":[0.9991561,0.0002208482,0.0001331601,0.00009232895,0.00003591182,0.0003616262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6383714,0.09939995,0.01179599,0.0005254042,0.001496928,0.000832426,0.0006828154,0.005796608,0.089699,0.0007177336,0.005887816,0.144794],"study_design_scores_gemma":[0.3194932,0.6347851,0.02425885,0.00002812187,0.0007977207,0.001014838,0.0001457231,0.004417275,0.01049934,0.0003190285,0.004157736,0.00008315143],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995783,0.001025563,0.000498328,0.0003255513,0.00008950373,0.0005007093,0.0004837331,0.00007754957,0.001216111],"genre_scores_gemma":[0.9942508,0.001262408,0.001235681,0.0003461074,0.0001464565,0.0004327785,0.0009754995,0.00004884079,0.00130135],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002291573,"threshold_uncertainty_score":0.008213043,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008409667718402071,"score_gpt":0.2599263105277969,"score_spread":0.2515166428093948,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}